[HTML][HTML] Radiolabeled somatostatin analogs—a continuously evolving class of radiopharmaceuticals
M Fani, R Mansi, GP Nicolas, D Wild - Cancers, 2022 - mdpi.com
Simple Summary Somatostatin receptors (SSTs) are of particular interest in oncology
because these proteins are overexpressed on the cell membranes of different human …
because these proteins are overexpressed on the cell membranes of different human …
Imaging-guided targeted radionuclide tumor therapy: From concept to clinical translation
J Sun, Z Huangfu, J Yang, G Wang, K Hu, M Gao… - Advanced Drug Delivery …, 2022 - Elsevier
Since the first introduction of sodium iodide I-131 for use with thyroid patients almost 80
years ago, more than 50 radiopharmaceuticals have reached the markets for a wide range …
years ago, more than 50 radiopharmaceuticals have reached the markets for a wide range …
[HTML][HTML] Combination of terbium-161 with somatostatin receptor antagonists—a potential paradigm shift for the treatment of neuroendocrine neoplasms
F Borgna, S Haller, JMM Rodriguez, M Ginj… - European journal of …, 2022 - Springer
Purpose The β¯-emitting terbium-161 also emits conversion and Auger electrons, which are
believed to be effective in killing single cancer cells. Terbium-161 was applied with …
believed to be effective in killing single cancer cells. Terbium-161 was applied with …
[HTML][HTML] Efficacy and safety of 225Ac-DOTATATE targeted alpha therapy in metastatic paragangliomas: a pilot study
MP Yadav, S Ballal, RK Sahoo, C Bal - European Journal of Nuclear …, 2022 - Springer
Purpose In this study, we aim to evaluate the efficacy and safety of 225 AC-DOTATATE
targeted alpha therapy in advanced-stage paragangliomas (PGLs). Methods Nine (6 males …
targeted alpha therapy in advanced-stage paragangliomas (PGLs). Methods Nine (6 males …
Peptide receptor radionuclide therapy
J Hofland, T Brabander, FA Verburg… - The Journal of …, 2022 - academic.oup.com
The concept of using a targeting molecule labeled with a diagnostic radionuclide for using
positron emission tomography or single photon emission computed tomography imaging …
positron emission tomography or single photon emission computed tomography imaging …
[HTML][HTML] The evolution of PRRT for the treatment of neuroendocrine tumors; What comes next?
PE Harris, K Zhernosekov - Frontiers in Endocrinology, 2022 - frontiersin.org
Lu-177 has been developed for the treatment of patients with peptide receptor radionuclide
therapy (PRRT). A second generation pure no-carrier-added Lu-177 has a high specific …
therapy (PRRT). A second generation pure no-carrier-added Lu-177 has a high specific …
[HTML][HTML] New PET radiotracers for the imaging of neuroendocrine neoplasms
E Fortunati, G Argalia, L Zanoni, S Fanti… - … Treatment Options in …, 2022 - Springer
Opinion statement Neuroendocrine neoplasms (NEN) are a heterogeneous group of
tumours derived from cells of neuroendocrine origin and can potentially arise everywhere in …
tumours derived from cells of neuroendocrine origin and can potentially arise everywhere in …
Role of 18F-FDG PET/CT in large vessel vasculitis and polymyalgia rheumatica
RHJA Slart, PH Nienhuis… - Journal of Nuclear …, 2023 - Soc Nuclear Med
Systemic vasculitides comprise a group of autoimmune diseases affecting blood vessels,
including large vessel vasculitis (LVV) and medium-sized vessel vasculitis such as giant cell …
including large vessel vasculitis (LVV) and medium-sized vessel vasculitis such as giant cell …
[HTML][HTML] Alpha-peptide receptor radionuclide therapy using actinium-225 labeled somatostatin receptor agonists and antagonists
Peptide receptor radionuclide therapy (PRRT) has over the last two decades emerged as a
very promising approach to treat neuroendocrine tumors (NETs) with rapidly expanding …
very promising approach to treat neuroendocrine tumors (NETs) with rapidly expanding …
[HTML][HTML] Peptide receptor radionuclide therapy (PRRT): innovations and improvements
E Merola, CM Grana - Cancers, 2023 - mdpi.com
Simple Summary This article discusses the use of peptide receptor radionuclide therapy
(PRRT) as a key treatment method for advanced, unresectable neuroendocrine tumors. It …
(PRRT) as a key treatment method for advanced, unresectable neuroendocrine tumors. It …